Press release
Major Growth Driver Identified in 2025 Inhalable Drugs Market: Surge In Respiratory Diseases Propels Growth Of Inhalable Drug Market
Inhalable Drugs
Inhalable Drugs Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for inhalable medications has seen considerable expansion in the past few years. The market worth, projected to jump from $35.06 billion in 2024 to $37.27 billion in 2025, reflects a compound annual growth rate (CAGR) of 6.3%. The historical growth of this market is credited to factors such as the rising elderly population, patient inclination towards non-invasive treatment procedures, intensifying emphasis on respiratory health, and the expansion of emerging markets.
Inhalable Drugs Market Size Forecast: What's the Projected Valuation by 2029?
The market size for inhalable drugs is predicted to experience significant expansion in the coming years. The market is expected to reach a valuation of $50 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 7.6%. The pacesetters for this projected growth within the forecast period include the rise in healthcare expenditure, increasing demand for biologics, a heightened focus on personalized medication, and regulatory endorsement for orphan drugs. The key trends during the forecast period would be the development of advanced respiratory medicines in veterinary science, technological advancements, and better reimbursement policies.
View the full report here:
https://www.thebusinessresearchcompany.com/report/inhalable-drugs-global-market-report
What Are the Drivers Transforming the Inhalable Drugs Market?
The surge in respiratory ailments is forecasted to fuel the expansion of the inhalable drug market. Respiratory ailments comprise health issues impacting the respiratory system, encompassing lungs, bronchi, trachea, larynx, pharynx, and nose. Inhalable drugs serve a vital role in treating numerous respiratory disorders effectively since they deliver medicine straight to the lungs. For instance, as per the Australian Bureau of Statistics, a government agency based in Australia, in 2022, 2.5% of the population (638,100 individuals) were diagnosed with COPD, with marginal differences in incidences in males (2.4%) and females (2.6%). Those who smoked every day had a much higher likelihood of COPD (8.1%) compared to former smokers (4.4%) and those who never smoked (1.6%). Hence, the surge in respiratory diseases prevalence will shape the future inhalable drug market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12490&type=smp
What Long-Term Trends Will Define the Future of the Inhalable Drugs Market?
Product development innovations are emerging as a significant trend in the inhalable drug market. To maintain a competitive edge, top firms in this market sector are concentrating on enhancing the advanced features of inhalable drugs. For instance, in July 2022, DMV-Fonterra Excipients GmbH & Co. KG, a German pharmaceutical firm, broadened its dry powder inhalation (DPI) product range with the introduction of Lactohale 400. This novel grade is versatile and can be tailored to address the specific requirements of various pharma companies and was collaboratively developed with formulators to optimize patient outcomes. Its broad range of lactose-based additives is designed to offer the right attributes for a variety of inhaled treatments. Lactohale 400 is a finely ground, dry type of lactose suitable for DPI applications that demand high flow and adherence. It's the product's anhydrous quality that distinguishes it from common lactose carriers, resulting in a unique aerosolization performance compared to lactose monohydrate of the same particle size.
Which Segments in the Inhalable Drugs Market Offer the Most Profit Potential?
The inhalable drugs market covered in this report is segmented -
1) By Product: Aerosol, Dry Powder Formulation, Spray
2) By Distribution Channel: Hospital Pharmacy, Pharmacy Stores, Other Distribution Channels
3) By Application: Respiratory Diseases, Non-Respiratory Diseases
4) By End Users: Adults, Pediatric, Geriatric
Subsegments:
1) By Aerosol: Metered Dose Inhalers (MDIs), Nebulizers, Soft Mist Inhalers
2) By Dry Powder Formulation: Dry Powder Inhalers (DPIs), Blister Packs, Capsules
3) By Spray: Nasal Sprays, Oral Sprays, Subcutaneous Sprays
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12490&type=smp
Which Firms Dominate the Inhalable Drugs Market by Market Share and Revenue in 2025?
Major companies operating in the inhalable drugs market include Pfizer Inc., Merck & Co. Inc., Novartis AG, Sanofi SA, AstraZeneca plc, GlaxoSmithKline Plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Catalent Inc., Sumitomo Pharma Co. Ltd., Intertek Group plc, AptarGroup Inc., Cipla Inc., Glenmark Pharmaceuticals Inc., Piramal Pharma Ltd., Zambon S.p.A., Sunovion Pharmaceuticals Inc., Nelson Laboratories LLC, Vectura Group Limited, Abiogen Pharma, Quotient Sciences, AeroGen Pharma, Alaxia S.A.S., Pharmaxis Ltd., Avalyn Pharma Inc., TFF Pharmaceuticals Inc.
Which Regions Offer the Highest Growth Potential in the Inhalable Drugs Market?
North America was the largest region in the inhalable drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inhalable drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12490
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Major Growth Driver Identified in 2025 Inhalable Drugs Market: Surge In Respiratory Diseases Propels Growth Of Inhalable Drug Market here
News-ID: 4107415 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Inhalable
Inhalable Biologics Market is on an Upward Growth Curve
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Digital Health Coaching Market - By Type (Peptides And Proteins, Vaccines, Monoclonal Antibodies, RNAi-Based Therapeutics), Application (Respiratory Diseases, Diabetes, Cancer), Dosage Form (Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers), And Distribution Channel (Hospital Pharmacies, Retail Pharmacies, And Online Pharmacies), Trends, Industry Competition Analysis, Revenue And Forecast To 2034."
The global inhalable biologics market is estimated to…
Inhalable Drugs: Transforming Respiratory Healthcare Delivery
The Business Research Company recently released a comprehensive report on the Global Inhalable Drugs Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Inhalable Drugs Market 2024 Insights and Precise Outlook 2031
The global inhalable drugs market is projected to experience a notable compound annual growth rate (CAGR) of 6.3% throughout the forecast period. In recent years, the global Inhalable Drugs Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Inhalable Drugs Market presents a complete judgment of the market through strategic insights on future trends, growth factors,…
Inhalable Drugs Market Size, Outlook, Overview 2024-2033
The inhalable drugs market size has grown strongly in recent years. It will grow from $33.29 billion in 2023 to $35.48 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to increased geriatric population, patient preference for non-invasive treatments, increased focus on respiratory health, emerging markets growth.
The inhalable drugs market size is expected to see strong…
Inhalable Drug Market Insights on Scope and Growing Demands
Inhalable Drug Market Insights Unveiled:
Inhaled drugs, commonly known as "inhalants," are gaining traction as a preferred method of administration, driven by the increasing prevalence of respiratory and non-respiratory disorders. The rising incidence of conditions such as asthma, COPD, and cystic fibrosis is a key factor influencing market dynamics. According to the Centers for Disease Control and Prevention (CDC), asthma alone affected more than 25 million individuals in the US in…
Inhalable Biologics Market Value Share, Supply Demand, share and Value Chain 201 …
Each year, millions of people are affected by respiratory diseases across the world, due to which, the use of inhalable biologics is also increasing. Inhalable biologics are agents that are formed from the products of living (plant or microorganisms) sources, which are used for treating chronic diseases and acute diseases such as asthma, COPD, and cystic fibrosis, among others. Inhalable biologics are beneficial over the conventional systems because of their…
